Loading company
Latest annual · FY2025
Millions- Total revenues
- 6
- Operating income
- (122)
- Net income
- (117)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Operating income
- (18)
- Net income
- (18)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- -29.6%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Korro Bio, Inc. (KRRO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $6.4 million | $2.3 million | +181.5% | 10-K 2026-03-12 · proof |
| Operating income | -$121.9 million | -$91.9 million | 10-K 2026-03-12 · proof | |
| Net income | -$117.3 million | -$83.6 million | 10-K 2026-03-12 · proof | |
| Total assets | $113.5 million | $226.2 million | -49.8% | 10-K 2026-03-12 · proof |
| Total liabilities | $62.1 million | $65.8 million | -5.7% | 10-K 2026-03-12 · proof |
| Cash and cash equivalents | $21.8 million | $55.6 million | -60.8% | 10-K 2026-03-12 · proof |
- What was Korro Bio, Inc. (KRRO)'s revenue in fiscal 2025?
- Korro Bio, Inc. (KRRO) reported revenue of $6.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $2.3 million the year before (+181.5%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was Korro Bio, Inc. (KRRO)'s operating income in fiscal 2025?
- Korro Bio, Inc. (KRRO) reported operating income of -$121.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$91.9 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was Korro Bio, Inc. (KRRO)'s net income in fiscal 2025?
- Korro Bio, Inc. (KRRO) reported net income of -$117.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$83.6 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are Korro Bio, Inc. (KRRO)'s total assets?
- As of Dec 31, 2025, Korro Bio, Inc. (KRRO) reported total assets of $113.5 million, against $226.2 million a year earlier (-49.8%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are Korro Bio, Inc. (KRRO)'s total liabilities?
- As of Dec 31, 2025, Korro Bio, Inc. (KRRO) reported total liabilities of $62.1 million, against $65.8 million a year earlier (-5.7%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are Korro Bio, Inc. (KRRO)'s cash and cash equivalents?
- As of Dec 31, 2025, Korro Bio, Inc. (KRRO) reported cash and cash equivalents of $21.8 million, against $55.6 million a year earlier (-60.8%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:KRRO&period_type=annual&limit=5"Information only, not investment advice.